Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: A critical review of the literature

Journal of Clinical Oncology

Volumn 20, Issue 11, 2002, Pages 2736-2744

  Vicini, Frank A ^a   Recht, Abram ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARCINOMA IN SITU; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT;

EID: 0036605570     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.07.137     Document Type: Review

References (62)

1. Prognostic significance of young age in breast cancer
2. Factors influencing the effect of age on prognosis in breast cancer: Population based study
3. Breast cancer in young women
4. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer
5. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study
6. Institut Curie experience
7. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS)
8. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853
9. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy
10. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B- 24 randomised controlled trial
11. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: Long-term outcome and prognostic significance of patient age and margin status
12. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: The effect of age
13. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ
14. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B- 17
15. The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy
16. Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast
17. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: Patterns of failure and 10-year results
18. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age
19. Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy
20. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy
21. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting
22. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age
23. Intraductal extension of primary invasive breast carcinoma treated by breast-conserving surgery: Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems
24. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor
25. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast
26. Volume of resection in patients treated with breast conservation for ductal carcinoma in situ
27. Local-regional recurrence after mastectomy or breast-conserving surgery
28. Breast carcinoma in situ: A retrospective review of 112 cases with a minimum 10 year follow-up
29. Intraductal carcinoma: Analysis of presentation, pathologic findings, and outcome of disease
30. Influence of local treatment on the recurrence rate of ductal carcinoma in situ
31. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast
32. Management and survival of female patients with "minimal" breast cancer: As observed in the long-term and short-term surveys of the American College of Surgeons
33. Carcinoma in situ of the breast
34. Intraductal "noninfiltrating" carcinoma of the breast
35. Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures
36. In situ intraduct carcinoma of the breast: A long term follow-up study
37. Intraductal carcinoma of the breast: A comparative study
38. In situ carcinoma of the breast
39. Breast carcinoma in situ
40. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): I. Intraductal carcinoma (DCIS)
41. Prospective study of non-infiltrating carcinoma of the breast
42. Intraductal carcinoma of the breast: (1960-1969)
43. Current concepts in the detection and treatment of the earliest of the early breast cancers
44. Improved prognosis in certain patterns of carcinoma of the breast
45. Role of simple mastectomy in treating patients with breast cancer
46. Follow-up of two treatment modalities for ductal cancer in situ of the breast
47. Surgical treatment of ductal carcinoma in situ of the breast: 10-to 20-year follow-up
48. Noninvasive breast carcinoma: Results of a national survey by the American College of Surgeons
49. In situ ductal carcinoma of the breast: Implications of disease pattern and treatment
50. Intraductal breast carcinoma: Review of a multicenter series of 350 cases-Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy
51. Recurrent ductal carcinoma in situ after total mastectomy
52. Ductal carcinoma in situ recurrent on the chest wall after mastectomy
53. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy
54. Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy
55. Recurrence after breast ablation for ductal carcinoma in situ
56. Is mammography useful in screening for local recurrences in patients with TRAM flap breast reconstruction after mastectomy for multifocal DCIS?
57. Mammographic appearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructions
58. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy
59. Subclinical ductal carcinoma in situ of the breast: Treatment with conservative surgery and radiotherapy
60. The current status of the treatment of ductal carcinoma in situ of Japanese women, especially breast conserving operation in relation to the surgical margin and short term outcome
61. The impact of young age on outcome after breast-conserving surgery (BCS) and radiation therapy (RT) for carcinoma in situ of the breast (DCIS)
62. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast